These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2006407)

  • 1. And the winner: Cetus does own PCR.
    Barinaga M
    Science; 1991 Mar; 251(4998):1174. PubMed ID: 2006407
    [No Abstract]   [Full Text] [Related]  

  • 2. Biotech nightmare: does Cetus own PCR?
    Barinaga M
    Science; 1991 Feb; 251(4995):739-40. PubMed ID: 1990435
    [No Abstract]   [Full Text] [Related]  

  • 3. New rulings on the Cetus patent for taq polymerase.
    Leonard DG; Schifreen RS; Sninsky JJ; White TJ
    Mol Diagn; 2000 Mar; 5(1):1-3. PubMed ID: 10837081
    [No Abstract]   [Full Text] [Related]  

  • 4. Cetus retains PCR patents.
    Schaefer E
    Nature; 1991 Mar; 350(6313):6. PubMed ID: 2002846
    [No Abstract]   [Full Text] [Related]  

  • 5. Cetus battles with Du Pont.
    Gershon D
    Nature; 1990 Jan; 343(6256):301. PubMed ID: 2300180
    [No Abstract]   [Full Text] [Related]  

  • 6. Cetus and Chiron merge.
    Gershon D
    Nature; 1991 Aug; 352(6334):364. PubMed ID: 1861710
    [No Abstract]   [Full Text] [Related]  

  • 7. Promega and Roche take up battle over PCR patents.
    Dalton R
    Nature; 2000 Mar; 404(6773):7. PubMed ID: 10716415
    [No Abstract]   [Full Text] [Related]  

  • 8. PCR. Roche dealt a setback on European Taq patent.
    Service RF
    Science; 2001 Jun; 292(5523):1815. PubMed ID: 11397920
    [No Abstract]   [Full Text] [Related]  

  • 9. Biotechnology patents: Dupont battles with Cetus.
    McGourty C
    Nature; 1989 Nov; 342(6245):9. PubMed ID: 2812005
    [No Abstract]   [Full Text] [Related]  

  • 10. Biotechnology patents. Genentech wins round two.
    Gershon D
    Nature; 1990 Apr; 344(6268):692. PubMed ID: 2109830
    [No Abstract]   [Full Text] [Related]  

  • 11. PCR. Taq polymerase patent ruled invalid.
    Service RF
    Science; 1999 Dec; 286(5448):2251, 2253. PubMed ID: 10636779
    [No Abstract]   [Full Text] [Related]  

  • 12. "Ganske" threatens biotechnology patents worldwide.
    Glaser V
    Nat Biotechnol; 1997 Feb; 15(2):121. PubMed ID: 9035128
    [No Abstract]   [Full Text] [Related]  

  • 13. Biotechnology and patent term extension issues.
    Raines L
    Food Drug Law J; 1999; 54(2):237-40. PubMed ID: 11758579
    [No Abstract]   [Full Text] [Related]  

  • 14. Patent prosecution of biotechnology and pharmaceutical patents in a changing legal landscape.
    Lu DL; Kowalski TJ; Jarecki-Black J
    Future Med Chem; 2010 Jan; 2(1):7-9. PubMed ID: 21426040
    [No Abstract]   [Full Text] [Related]  

  • 15. The biotechnology industry organization's view on Hatch-Waxman reform.
    Schmickel D
    Food Drug Law J; 1999; 54(2):241-2. PubMed ID: 11758580
    [No Abstract]   [Full Text] [Related]  

  • 16. Roche eases PCR restrictions.
    Hoffman M
    Science; 1992 Jan; 255(5044):528. PubMed ID: 1736354
    [No Abstract]   [Full Text] [Related]  

  • 17. Promega wins round in fight over Taq.
    Barinaga M
    Science; 1996 Aug; 273(5278):1039. PubMed ID: 8711480
    [No Abstract]   [Full Text] [Related]  

  • 18. Hemispherx: 300 patents, 20 staff.
    Chahine K
    Nat Biotechnol; 1997 Jul; 15(7):612-3. PubMed ID: 9219255
    [No Abstract]   [Full Text] [Related]  

  • 19. PCR enzyme. The more you use, the cheaper it gets.
    Aldhous P
    Science; 1993 Aug; 261(5122):678. PubMed ID: 8342033
    [No Abstract]   [Full Text] [Related]  

  • 20. Intellectual property. Research centers promise a break on medical patents in developing countries.
    Kean S
    Science; 2009 Nov; 326(5956):1051. PubMed ID: 19965400
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.